1. Introduction {#Section1}
===============

It is generally accepted that oxidative stress could induce cell damage and lead to a variety of neurodegenerative disorders such as Parkinson\'s and Alzheimer\'s diseases [@B1]-[@B3]. Hydrogen peroxide (H~2~O~2~) is one of the reactive oxygen species which could lead to lipid peroxidation and DNA damage [@B4], [@B5]. H~2~O~2~could induce the production of reactive oxygen species (ROS) in the brain. Recent studies have demonstrated that high levels of ROS induce nervous system cell death [@B8]-[@B10]. Mammalian cells have developed several protective mechanisms involving both antioxidants and protective enzymes to defend ROS damage [@B11], [@B12]. HO-1 is one of antioxidant enzymes with potent anti-inflammatory, anti-oxidant and anti-proliferative effects [@B13]-[@B15]. HO-1 is known as a heat shock protein induced by the oxidative stress. In clinical practice, increased HO-1 expression prolongs cardiac xenograft survival, facilitates cold preservation of liver transplants and reduces the severity of ischemia reperfusion injury in kidney transplants [@B16]-[@B18]. In addition, overexpression of HO-1 also has effective neuroprotection against cold-induced secondary brain injury [@B19]. The expression of HO-1 could be induced by a range of substances, such as H~2~O~2~, phlorotannin compound, heavy metals, endotoxin, organic chemicals and so on [@B20]-[@B22]. Acquaviva et al. [@B23] showed that propofol induces expression of HO-1 in astrocytes under normal conditions. Expression of HO-1 has related to the several signal transduction pathways, such as mitogen-activated protein kinases (MAPKs) including extracellular signal-regulated kinases (ERKs), cJun-N-terminal kinases (JNKs) and p38-MAPK, depending on cell species and treatment conditions [@B24]-[@B27]. The expression also requires the activation of several signal transduction pathways such as protein kinase C (PKC) and phosphatidylinositol 3-kinase (PI3K) [@B28].

Propofol (2, 6-diisopropylphenol, Fig [1](#F1){ref-type="fig"}) was always described as an anesthetic [@B29]. Propofol produces a variety of pharmacodynamic effects, such as hypnosis to general anesthesia; relax amnestic and muscle; decrease the production of pro-inflammatory cytokines and alters the biosynthesis of nitric oxide (NO) [@B30], [@B31]. Additionally, propofol also could inhibit chemotaxis, attachment, migration, phagocytosis, the production of ROS and so on [@B32]. The protective effects of propofol were attributed to its capability of scavenging H~2~O~2~, reducing the formation of lipid peroxides, decreasing the expression levels of nitric oxide syntheses, and stabilizing the mitochondrial membrane [@B33], [@B34].

In the present study, we investigated a mechanism by the protection of propofol for SH-SY5Y cells from H~2~O~2~ induced oxidative damage. Furthermore, the possible signaling way was examined to understand the mechanisms. We also investigated the effect of propofol on expression of HO-1 in SH-SY5Y cells under oxidative stress conditions.

2. Results and Discussion {#Section2}
=========================

2.1. Propofol inhibits H~2~O~2~-induced SH-SY5Y cell death {#Section2.1}
----------------------------------------------------------

First, the cytotoxicity effects propofol on SH-SY5Y cells after 24 h exposure were examined (Figure [2](#F2){ref-type="fig"}a). The relative cell survival rate of SH-SY5Y cells treated with 0-100 µM propofol was over 80%, as analyzed by the MTT assay. Then, the effect of propofol on H~2~O~2~-induced cell death was determined. SH-SY5Y cells were treated with propofol (25-100 μM) or vehicle for 8 h, after that, the cells was exposed to 1 mM H~2~O~2~ or vehicle in fresh medium for 24 h. As shown in Fig. [2](#F2){ref-type="fig"}b, the survival rates of SH-SY5Y cells treated with 25 µM, 50 µM, 75 µM and 100 µM propofol were 60.94 %, 72.19 %, 80.43 % and 87.3 % respectively. The results indicate that a dose of 0-100 µM propofol does not contribute significantly to cytotoxicity in SH-SY5Y cells, and affords cytoprotection to the cell cultures in a concentration-dependent manner. Taken together, these data show that propofol inhibits H~2~O~2~-induced apoptosis in SH-SY5Y cells.

2.2. Propofol Reduces H~2~O~2~-induced ROS Production of SH-SY5Y cell {#Section2.2}
---------------------------------------------------------------------

To determine whether propofol reduced H~2~O~2~-induced ROS generation in SH-SY5Y cells, cells were treated with propofol (0-100 μM) for 8 h and then incubated with 1 mM H~2~O~2~ or vehicle for 24 h. After that cells were treated with 25 μM H~2~-DCFDA for 1 h. As shown in Fig. [3](#F3){ref-type="fig"}, treatment with propofol significantly reduced the H~2~O~2~-induced ROS generation, indicating that propofol attenuates ROS production.

2.3. ERK Signaling Pathways Participate in the propofol-Induced HO-1 Expression {#Section2.3}
-------------------------------------------------------------------------------

To analyze the signaling pathway that could participate in the neuroprotective mechanism of propofol, the effect of propofol on extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase (JNK) and p 38 mitogen-activated protein kinase (p 38 MAPK) activation in SH-SY5Y cells was investigated. Propofol stimulated concentration increases in ERK, JNK and p 38 MAPK phosphorylation in H~2~O~2~ induced SH-SY5Y cells (Fig [4](#F4){ref-type="fig"}). Moreover, PD98059 (an inhibitor of the ERK), SB203580 (an inhibitor of p 38 MAP kinase), and SP600125 (an inhibitor of JNK) were used in pretreatment of SH-SY5Y cells for 30 min, and then cells were co-treated with 100 µM propofol for another 8 h, cells were incubated for 24 h in the presence of H~2~O~2~ and cell lysates were resolved in SDS-PAGE and analyzed by immunoblot with anti-HO-1 antibody (Fig [5](#F5){ref-type="fig"}). Propofol increased the expression of HO-1, compared with control cells. Co-incubation of the cells with propofol, H~2~O~2~ and the ERK inhibitor PD98059 reduced the overexpression of HO-1, indicating that ERK was implicated in the overexpression of HO-1, induced by propofol. Moreover, JNK inhibitor and p 38 MAPK inhibitor did not block the overexpression of HO-1(Fig. [4](#F4){ref-type="fig"}-b). These results indicate that ERK is participating in the overexpression of HO-1 afforded by propofol.

2.4 ERK Signaling Pathways Participate in the propofol Reduces H~2~O~2~-induced SH-SY5Y cell death and ROS Production {#Section2.4}
---------------------------------------------------------------------------------------------------------------------

To confirm the role of ERK Signaling Pathways during oxidant-mediated apoptosis, we used H~2~O~2~ as the apoptosis inducer. According to our experiments described before, PD98059 (an inhibitor of the ERK) or vehicle were used in pretreatment of SH-SY5Y cells for 30 min, and then cells were co-treated with 100 µM propofol for another 8 h, after that, the cells was exposed to 1 mM H~2~O~2~ or vehicle in fresh medium for 24 h as analyzed by an MTT assay. For ROS production assay, PD98059 or vehicle were used in pretreatment of SH-SY5Y cells for 30 min, then cells were treated with 100 μM propofol or vehicle for 8 h and treated 1 mM H~2~O~2~ or vehicle for 24 h. Flowed that cells was treated with H~2~-DCFDA for 20 min, samples were analyzed by BD Flow cytometry with channel FL1, and the data were shown in Fig.[5](#F5){ref-type="fig"}. From Fig.[5](#F5){ref-type="fig"}, treatment with propofol significantly reduced the H~2~O~2~-induced SH-SY5Y cell death and ROS generation, but co-incubation of the cells with propofol, H~2~O~2~ and the ERK inhibitor PD98059 increase the SH-SY5Y cell death and ROS Production, indicating that the ERK inhibitor attenuates the effect of propofol in SH-SY5Y cell.

The purpose of this study was to elucidate the role of propofol in SH-SY5Y under oxidative stress. All data provide strong evidence that propofol could protect SH-SY5Y against oxidative stress via the ERK pathway and induction of the antioxidant enzyme HO-1. Propofol was able to protect neuroblastoma cells against oxidant stress as observed [@B35]. For example, the survival rates of SH-SY5Y cells treated with 25 µM-100 µM propofol were increase compared with cells untreated with propofol (47.11 %). This result refers that the high concentrations of propofol against H~2~O~2~ could be exerting a direct free radical scavenging effect. The antioxidant enzyme HO-1 was induced by propofol which related to the blocking ROS production as shown in the experiments with the fluorescent dye H~2~-DCFDA. Therefore propofol was able to reduce ROS production induced by H~2~O~2~ treatment both endogenous and exogenous [@B36]. HO-1 is an isoform which belongs to HO antioxidant enzyme induced in response to a variety of stress-inducing pathological conditions such as prolongs cardiac xenograft survival; facilitates cold preservation of liver transplants and so on. Maines [@B37] found that there is a low expression of HO-1 induced by H~2~O~2~ in neurons. Therefore, HO-1 represents a physiological protective mechanism against oxidative stress is generally accepted [@B38], [@B39]. In this study, propofol was able to up-regulate HO-1 and this effect was related to the protective effects of propofol.

The fact that propofol-induced protective effect was prevented by the ERK inhibitor indicates that ERK pathway is participating in the induction of antioxidant enzyme HO-1. Our results are consistent with those which were found for the propofol protected cells against ischemia/reperfusion injury in liver epithelial cells [@B40]. Based on our present results, propofol exerts a protective effect by modulating signaling pathways in neuronal cells under oxidative stress. Collectively, the data suggest that propofol reduced cell death and ROS production which induced by H~2~O~2~ via ERK pathway. Further studies are needed to delineate the detailed mechanisms of activating ERK pathway by propofol, and which protein was in cooperation with HO-1 during oxidative stress-induced neuronal to reduce cell death.

In summary, this study shows that propofol can afford protection of SH-SY5Y neuroblastoma cells under oxidative stress conditions by induction of the antioxidant enzyme HO-1 via ERK pathway. This finding may have neuroprotective properties that might be useful in the acute treatment of stroke, to prevent neuronal damage and the ensuing neurological sequelae.

3. Experimental {#Section3}
===============

3.1. Cell Culture {#Section3.1}
-----------------

The human neuroblastoma SH-SY5Y cells were maintained in MEM medium supplemented with 10% fetal calf serum, 100 U/ml penicillin and 100 U/ml streptomycin in a humid atmosphere of 5% CO~2~ and 95% air at 37 °C. SH-SY5Y cells were plated in plates (10 cm). Then cells were pretreated with various concentrations (0-100 μM) of propofol for 8 h, followed by exposure to 1 mM of H~2~O~2~in the presence of the same concentrations of propofol for another 24 h. To produce oxidative stress, H~2~O~2~ was freshly prepared from 30% stock solution prior to each experiment. The control cells were added with the same medium without H~2~O~2~ and propofol.

3.2. Chemicals and Antibodies {#Section3.2}
-----------------------------

Propofol was prepared from Diprivan (Zeneca Limited, Macclesfield, and Cheshire, UK). The vehicle contained glycerol, soybean oil, purified egg phosphatide/egg lecithin, sodium hydroxide, and water. 3-\[4, 5-dimethyl-2-thiazolyl\]-2, 5-diphenyl-2-tetrazolium bromide (MTT) were purchased from Sigma. Other drugs and reagents used in this study were as follows: PD98059 (an inhibitor of the ERK), SB203580 (an inhibitor of p 38 MAP kinase), and SP600125 (an inhibitor of JNK) [@B41] were obtained from Cell Signaling Technology (Beverly, MA, USA). Antibodies against HO-1 and β-actin were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Mouse monoclonal beta-actin antibody was obtained from Chemicon (Temecula, CA, USA). All other reagents were from commercial suppliers and of standard biochemical quality.

3.3. Viability Assay {#Section3.3}
--------------------

SH-SY5Y cells were plated at a density of 1×10^4^ cells per well in 96-well plates, and the cell viability was determined using the conventional MTT reduction assay. Briefly, after 24 h exposure to H~2~O~2~, 40 μl of MTT (2 mg/ml in PBS) were added to each well and the cells were incubated at 37 °C for 4 h. The supernatants were aspirated carefully and 100 μl of dimethyl sulfoxide (DMSO) were added to each well to dissolve the precipitate and the absorbance at 490 nm was measured with a microplate reader (BIO-RAD Model 3550, CA, USA). The cell viability ratio was calculated by the following formula: Inhibitory ratio (%) = \[(OD~control~ − OD~treated~) / (OD~control~)\] × 100%.

3.4. Flow cytometric detection of reactive oxygen species (ROS) {#Section3.4}
---------------------------------------------------------------

ROS production in SH-SY5Y cells was measured using the redoxsensitive fluorescent dye H~2~- DCFDA. After pretreatment with propofol or vehicle 8 h, then treatment with 1 mM H~2~O~2~ for 24 h, cells were incubated with 25 μM H~2~-DCFDA for 20 min. The cells were rinsed twice with phenol-red-free DMEM containing 1% FBS, and fluorescence was detected on flow cytometry with FL1.

3.5. Western-Blot Analysis {#Section3.5}
--------------------------

For isolation of protein fractions, SH-SY5Y cells (1 × 10^6^) were seeded in a 6 cm plate and incubated at 37 °C for 24 h. Cells were pretreated with various concentrations of propofol for 8 h and then washed twice with ice-cold PBS, and lysed using cell lysis buffer \[20 mM Tris pH 7.5, 150 mM NaCl, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM EDTA, 1% Na~3~CO~4~, 0.5 g/mL leupeptin, 1 mM phenylmethanesulfonyl fluoride (PMSF)\]. The lysates were collected by scraping from the plates and then centrifuged at 10,000 rpm at 4 °C for 5 min. The protein samples (20 μg) were loaded on a 12% of SDS-polyacrylamide gel for electrophoresis, and transferred onto PVDF transfer membranes (Millipore, Billerica, MA, USA) at 0.8 mA/cm2 for 2 h. Membranes were blocked at room temperature for 2 h with blocking solution (1% BSA in PBS plus 0.05% Tween-20). Membranes were incubated overnight at 4 °C with primary anti-bodies at a 1:1000 dilution (Biosynthesis Biotechnology Company, Beijing, China) in blocking solution. After three washings in TBST for each 5 min, membranes were incubated for 1 h at room temperature with an alkaline phosphatase peroxidase-conjugated anti-mouse secondary antibody at a dilution of 1:500 in blocking solution. Detection was performed by the BCIP/NBT Alkaline Phosphatase Color Development Kit (Beyotime Institute of Biotechnology, Suzhou, China) according to the manufacturer\'s instructions. Bands were recorded by a digital camera (Canon, EOS 350D, Tokyo, Japan).

3.6. Statistical Analyses {#Section3.6}
-------------------------

Data are presented as means ± SEM. Differences were evaluated using unpaired Student\'s t-tests. The level of statistical significance was set at*p* \< 0.05.
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![Structure of propofol.](ijmsv10p0599g01){#F1}

![Propofol prevents H~2~O~2~-induced cell death; the results (presented as mean ± S.D.) are from three independent tests. (a) Cells were exposed to various concentrations of propofol for 24 h before being subjected to the MTT assay; (b) SH-SY5Y cells were treated with propofol (0-100 μM) for 8 h then incubated with H~2~O~2~ (1 mM) for a further 24 h, Cell viability was measured by MTT assays. \*\* and \*\*\* significant differences (P \< 0.01 and P \< 0.001 respectively) compared with 1 mM H~2~O~2~ group (the second bar).](ijmsv10p0599g02){#F2}

![Effect of propofol on intracellular ROS formation in SH-SY5Y cells, fluorescence was detected by flow cytometry with FL1; results (presented as mean ± S.D.) are from three independent tests. \*\* and \*\*\* significant differences (P \< 0.01 and P \< 0.001 respectively) compared with NC group. (a) Negative control; (b)-(f) Treatment with 0, 100, 75, 50 and 25 µM propofol respectively.](ijmsv10p0599g03){#F3}

![ERK signaling pathway participates in the propofol-induced HO-1 expression; results (presented as mean ± S.D.) are from three independent tests. (**a**) Cells were treated with propofol of different concentrations. Total cell extracts were prepared and subjected to western-blot analysis in order to detect the active phosphorylated forms of p 38 MAPK, ERK1/2 and JNK; (**b**) Cells were treated with 10 µM SB203580, SP600125, or PD98059 for 30 min and challenged with 100 µM propofol for another 8 h then incubated with H~2~O~2~for 24 h. Total cell extracts were prepared and subjected to western blot analysis for detection of the levels of HO-1.](ijmsv10p0599g04){#F4}

![ERK signaling pathway participate in the propofol reduces H~2~O~2~-induced SH-SY5Y cell death and ROS Production; results (presented as mean ± S.D.) are from three independent tests. (**A**) ERK signaling pathway participate in the propofol reduces H~2~O~2~-induced cell death. \*\* significant differences (P \< 0.01) compared with 1 mM H~2~O~2~ group (the second bar). (**B**) The ROS production assay. (B-a) Blank control; (B-b) SH-SY5Y cell was treated with H~2~O~2~; (B-c) SH-SY5Y cell were treated with H~2~O~2~and propofol; (B-d) The cells was treated with propofol for co-incubation, H~2~O~2~ and the ERK inhibitor PD98059. \*\*\* significant differences (P \< 0.001) compared with the blank control group (the first bar).](ijmsv10p0599g05){#F5}
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